Orphazyme A/S

(OTC: OZYMF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Orphazyme AS is a late-stage biopharmaceutical company harnessing the amplification of Heat Shock Proteins. It is engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for four severe orphan diseases: Niemann-Pick disease Type C (NPC), Gaucher disease, Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Contact Information

Website: www.orphazyme.com
Email: afv@orphazyme.com
Main Phone: +45 28989055
Address: Ole Maaloes Vej 3
City / Town: Copenhagen
Country: DK
Postal Code: DK-2200

Issuer Information

Exchange: OTO
CEO: Anders Vadsholt
Employees: 141

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A